Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

Novartis researcher Joana Silva had a life-changing experience with a mentor.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Genome editing advances drug discovery in biomedical research.

Researchers race to put hydroxychloroquine to the test in a large study.

Explaining Chagas disease through the stories of patients in Latin America.

Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.

Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.